Intervention
Latanoprost 0.005% Ophthalmic Solution (XALATAN)
ClinicalTrials.gov intervention label
Clinical trials
2 shownCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
Phase mix
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.